Evidence map›Paper›PMID 22583695›Full record

ArticleJournal of translational medicine2012

Increased HOX C13 expression in metastatic melanoma progression.

Monica Cantile, Giosuè Scognamiglio, Annamaria Anniciello, Marisa Farina, Giusy Gentilcore, Clemente Santonastaso, Franco Fulciniti, Clemente Cillo, Renato Franco, Paolo A Ascierto and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Disease models & mechanisms · 2020
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Monica CantilePathology Unit, Istituto Nazionale Tumori Fondazione G, Pascale, via Mariano Semmola, 80131, Naples, Italy. monicantile@libero.it
Giosuè Scognamiglio
Annamaria Anniciello
Marisa Farina
Giusy Gentilcore
Clemente Santonastaso
Franco Fulciniti
Clemente Cillo
Renato Franco
Paolo A Ascierto
Gerardo Botti
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe process of malignant transformation, progression and metastasis of melanoma is not completely understood. Recently, the microarray technology has been used to survey transcriptional differences that might provide insight into the metastatic process, but the validation of changing gene expression during metastatic transition period is poorly investigated. A large body of literature has been produced on the role of the HOX genes network in tumour evolution, suggesting the involvement of HOX genes in several types of human cancers. Deregulated paralogous group 13 HOX genes expression has been detected in melanoma, cervical cancer and odonthogenic tumors. Among these, Hox C13 is also involved in the expression control of the human keratin genes hHa5 and hHa2, and recently it was identified as a member of human DNA replication complexes.

methodsIn this study, to investigate HOX C13 expression in melanoma progression, we have compared its expression pattern between naevi, primary melanoma and metastasis. In addition HOXC13 profile pattern of expression has been evaluated in melanoma cell lines.

resultsOur results show the strong and progressive HOX C13 overexpression in metastatic melanoma tissues and cytological samples compared to nevi and primary melanoma tissues and cells.

conclusionsThe data presentated in the paper suggest a possible role of HOX C13 in metastatic melanoma switch.

Indexed as

Genes, HomeoboxBiomarkers, TumorCell Line, TumorDisease ProgressionFemaleHomeodomain ProteinsHumansImmunohistochemistryMaleMelanomaMiddle AgedNeoplasm MetastasisParaffin EmbeddingReal-Time Polymerase Chain ReactionBiomarkers, TumorHomeodomain ProteinsHOXC13 protein, human

Identifiers

PMID22583695
PMCPMC3478206
OpenAlexW2159883765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.